Home > News
|
Clinical Trials Update: Mar. 23, 2004 |
|
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
A research study of an investigational medication for the treatment of advanced renal cell cancer. Volunteers who have been diagnosed with advanced renal cell cancer, have had no previous anti-tumor therapy other than excision of primary tumor where appropriate and have no evidence of brain metastasis or clinically significant bleeding may be eligible. Research sites located throughout the United States, Canada and The Netherlands.
More information
Please see http://www.centerwatch.com/patient/studies/cat363.html.
-----
A research study of an investigational medication given in combination with chemotherapy for the treatment of non-small cell lung cancer. Volunteers who have Stage IIIB with pleural effusion or Stage IV non-small cell lung cancer and who have had no prior anti-tumor therapy may be eligible. Research sites located throughout the United States.
More information
Please see http://www.centerwatch.com/patient/studies/cat34.html.
-----
A research study of an investigational medication for the treatment of refractory lymphoma. Volunteers who have been diagnosed with refractory lymphoma (either Hodgkins or Non Hodgkins) who have had no prior anti-tumor therapy within four weeks of starting on the investigational medication may be eligible. Research sites located throughout the United States and Canada.
More information
Please see http://www.centerwatch.com/patient/studies/cat95.html.
-----
Copyright 2004 CenterWatch. All rights reserved.
Copyright © 2004 ScoutNews, LLC. All rights reserved.
HealthDayNews articles are derived from various sources and do not reflect federal policy. healthfinder® does not endorse opinions, products, or services that may appear in news stories. For more information on health topics in the news, visit the healthfinder® health library.
